Correlation Between Protagenic Therapeutics and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Connect Biopharma Holdings, you can compare the effects of market volatilities on Protagenic Therapeutics and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Connect Biopharma.
Diversification Opportunities for Protagenic Therapeutics and Connect Biopharma
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Protagenic and Connect is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Connect Biopharma go up and down completely randomly.
Pair Corralation between Protagenic Therapeutics and Connect Biopharma
Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 2.04 times more return on investment than Connect Biopharma. However, Protagenic Therapeutics is 2.04 times more volatile than Connect Biopharma Holdings. It trades about -0.01 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about -0.06 per unit of risk. If you would invest 66.00 in Protagenic Therapeutics on September 1, 2024 and sell it today you would lose (7.00) from holding Protagenic Therapeutics or give up 10.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protagenic Therapeutics vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Protagenic Therapeutics |
| Connect Biopharma |
Protagenic Therapeutics and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protagenic Therapeutics and Connect Biopharma
The main advantage of trading using opposite Protagenic Therapeutics and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.| Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |